Efficacy of Intermittent Androgen Deprivation Therapy vs Conventional Continuous Androgen Deprivation Therapy for Advanced Prostate Cancer: A Meta-analysis-Reference-Cited by-同舟云学术

Efficacy of Intermittent Androgen Deprivation Therapy vs Conventional Continuous Androgen Deprivation Therapy for Advanced Prostate Cancer: A Meta-analysis

Published:2013-08 Issue:2 Volume:82 Page:327-334
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Tsai Huei-Ting,Penson David F.,Makambi Kepher H.,Lynch John H.,Van Den Eeden Stephen K.,Potosky Arnold L.

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Urology

Reference26 articles.

1. Androgen suppression strategies for prostate cancer: is there an ideal approach?;Ismail;Curr Urol Rep,2011

2. Intermittent androgen deprivation for patients with recurrent/metastatic prostate cancer;Youssef;Am J Clin Oncol,2003

3. Prevalent and incident use of androgen deprivation therapy among men with prostate cancer in the United States;Gilbert;Urol Oncol,2009

4. Effects of androgen withdrawal on the stem cell composition of the Shionogi carcinoma;Bruchovsky;Cancer Res,1990

5. Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumor model;Sato;J Steroid Biochem Mol Biol,1996

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient Preferences for Attributes of Androgen Deprivation Therapies in Prostate Cancer: A Discrete Choice Experiment with Latent Class Analysis;Advances in Therapy;2024-08-21

2. Risk of cardiovascular events following intermittent and continuous androgen deprivation therapy in patients with nonmetastatic prostate cancer;Urologic Oncology: Seminars and Original Investigations;2024-07

3. Evaluation of the criteria for renewal of LHRH agonists in patients with prostate cancer: results of the ANAREN Study;Drugs in Context;2024-06-19

4. Identification of Factors Contributing to Testosterone Recovery After Hormone Therapy Combined With External Radiation Therapy;In Vivo;2024

5. Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update;Journal of Clinical Oncology;2023-07-10